We tested 102 Campylobacter jejuni and 6 Campylobacter coli clinical isolates from Poland. All were susceptible to erythromycin. Among the tested C. jejuni isolates 55.9% and 13.7% were resistant to ciprofloxacin and tetracycline, respectively. Replacement of Thr86 with Ile in GyrA and a plasmid-borne tet(O) gene were the main resistance mechanisms for fluoroquinolones and tetracycline, respectively.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1803138 | PMC |
| http://dx.doi.org/10.1128/AAC.01187-06 | DOI Listing |
Publication Analysis
Top Keywords
campylobacter jejuni
8
jejuni campylobacter
8
campylobacter coli
8
coli clinical
8
clinical isolates
8
isolates poland
8
antibiotic resistance
4
campylobacter
4
resistance campylobacter
4
poland tested
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!